Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rang in aandelen #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Aandeelprijs
$12.33
Laatst gesynchroniseerd: 2026-08-31
Marktkapitalisatie
$428.31M
Verandering (1 dag)
0.49%
Verandering (1 jaar)
39.01%
Land
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Categorie

Koersgeschiedenis voor Fennec Pharmaceuticals Inc. (FENC)
Hoogste slotkoers: $11.76 op 2026-08-01

Laagste slotkoers: $11.52 op 2017-09-01
Koersgeschiedenis van Fennec Pharmaceuticals Inc. van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 11.99%
2025 25.75%
2024 -39.44%
2023 2.87%
2022 131.45%
2021 -44.21%
2020 23.34%
2019 -0.18%
2018 -33.41%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.88 -10.84%
AU
$138.80 476.17%
US
$749.90 5.10%
CH